This month’s FOCUS on the diagnosis and management of myocardial disease in cardio-oncology provides to the general cardiologist—and anyone interested in the topic—relevant information on high-quality care to patients with cancer and cardiovascular conditions, or those at risk of developing them.

The issue delves into:

•    How to recognise the potential cardiotoxicity of antitumor treatments and the increased cardiovascular vulnerability of cancer survivors.
•    How the ESC cardio-oncology guidelines should be implemented in everyday clinical settings.
•    Understanding the various aspects of risk scores in myocardial disease in cardio-oncology.

The content of this issue was selected by Ronen Beeri, Maria Generosa Crespo Leiro, Teresa Lopez Fernandez, Stefano Nistri and Peter Van Der Meer.